article
Obesity, a multicausal global health disorder, requires innovative solutions beyond conventional weight control. Plant-derived prebiotics, like inulin, oligofructose, and resistant dextrin, have appeared as promising dietary interventions. These fibers nourish beneficial gut bacteria, which produce short-chain fatty acids (SCFAs) that regulate appetite, enhance fat combustion, and improve metabolic markers. Clinical trials show that the consumption of 8–21 g/day prebiotics for 8–24 weeks reduces body weight, BMI, waist circumference, inflammation, and insulin resistance. By exploring mechanisms, bioactive molecules, and personalized approaches, this review highlights prebiotics’ potential as natural anti-obesity agents. However, further research is needed to optimize their contribution to public health initiatives for the effective management of obesity.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.3390/blsf2025049013
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
